PMCK builds on solid healthcare demand as Kulim expansion and capacity upgrades support long-term growth

PMCK Berhad’s latest quarterly update continues to reflect a healthcare group that is steadily building for the longer term, backed by resilient demand, ongoing service enhancement and a clear expansion roadmap. For Q3 FY2026, the group recorded revenue of RM22.7 million and profit before tax of RM5.38 million, bringing 9M FY2026 revenue to RM69.88 million and 9M profit before tax to RM14.40 million. The quarter also included a RM3.02 million reversal of impairment following full settlement received in relation to previously undelivered COVID-19 vaccines.

A key point from both the official report and the management session is that PMCK’s business model remains anchored by steady demand for private healthcare services. The company said healthcare support services continued to be the main contributor to revenue, while inpatient care remained the main driver of patient care revenue. Management also highlighted that patient traffic remains healthy, with occupancy between 70% or to 80% when annualized, this was supported by the group’s role as an affordable community-focused private healthcare provider in Alor Setar.

That affordability angle continues to look like one of PMCK’s stronger selling points. During the briefing, management repeatedly stressed that the group focuses on delivering accessible healthcare to local communities rather than positioning itself as a premium, hotel-style operator. In the current environment, where patients and insurers are paying closer attention to healthcare costs, that positioning may give PMCK a practical advantage in sustaining volume and relevance.

The company is also actively strengthening its service base. In the official report, PMCK said it is continuing to recruit specialists in high-demand disciplines, enhance selected medical equipment and improve its digital ecosystem through electronic hospital information systems, digital appointment platforms and workflow automation. These initiatives are meant to improve patient experience and access, quality of care, operational efficiency and long-term resilience.

Management added more colour in the meeting, noting that the consultant base has expanded further since listing and that PMCK is also investing ahead in nursing talent to prepare for future capacity needs. This is especially relevant for the group’s next major phase of growth, as it wants to be ready operationally before new facilities come onstream.

The biggest medium-term catalyst remains PMC Kulim, which management indicated is still on track to commence operations in Q1 2028. The new hospital is planned as a 12-storey, 90-bed facility featuring five operating theatres, one endoscopy suite, three labour rooms and 45 specialist clinics. It is also expected to offer a full range of diagnostic and allied health support services, including physiotherapy with hydrotherapy capabilities, while the ICL is targeted to open at a later stage. Strategically positioned to serve the growing Kulim and Kulim Hi-Tech Park catchment, the project could strengthen the group’s presence in a rising healthcare demand corridor. Management also noted that the project structure helps mitigate exposure to construction cost volatility, which should support better execution visibility.

On the financial position, PMCK still appears to have a solid base to support its plans. As at 31 January 2026, the group reported total assets of RM205.55 million, cash and bank balances of RM23.72 million, and short-term investments of RM58.67 million. The company also disclosed that RM55.27 million of IPO proceeds remained available for utilisation, mainly for repayment of PMC Kulim-related borrowings and acquisition of equipment.

There is also some continuing support for the investment case from the shareholder-return angle. PMCK had already declared and paid an interim dividend of 0.12 sen per share, amounting to RM1.31 million, during the financial period. While no new dividend was declared for the current quarter under review, management’s tone in the meeting remained constructive on balancing returns with growth needs.

Another encouraging point from the briefing is that PMCK is not only focused on Kulim. Management said the group has identified four potential future locations, with two in the north and two in the south, while also keeping the door open for further expansion in Alor Setar. These plans are still at an early stage, but they show that management is thinking beyond a single-project story and looking at how to extend the group’s footprint over time.

Overall, PMCK’s latest quarter still points to a company that is executing on a broader growth plan. Demand for healthcare remains intact, service capacity is being strengthened, digitalisation is progressing, and the Kulim hospital continues to anchor the next stage of expansion. For investors looking at the bigger picture, PMCK appears to be laying the groundwork for a larger and more scalable private healthcare platform in the years ahead.